PMID- 19895327
OWN - NLM
STAT- MEDLINE
DCOM- 20110201
LR  - 20101013
IS  - 1471-1753 (Electronic)
IS  - 0954-6634 (Linking)
VI  - 21
IP  - 6
DP  - 2010 Nov
TI  - Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic 
      options?
PG  - 326-30
LID - 10.3109/09546630903341986 [doi]
AB  - Broadband ultraviolet B (BB-UVB) phototherapy has demonstrated efficacy in the 
      treatment of cutaneous disorders including psoriasis, atopic dermatitis, uremic 
      pruritus and idiopathic pruritus. In the last decade, there has been a rapidly 
      escalating process of replacing BB-UVB phototherapy units with narrowband 
      ultraviolet B (NB-UVB) equipment, as studies have demonstrated that NB-UVB 
      (ranging from 311 mm to 312 nm) is more efficacious in the treatment of 
      psoriasis. Nevertheless, it is important to recognize the efficacy of BB-UVB 
      phototherapy in the treatment of uremic pruritus, idiopathic pruritus, 
      eosinophilic folliculitis and other inflammatory pruritic conditions. 
      Furthermore, as highlighted in this report, there is a small but significant 
      proportion of psoriasis and atopic dermatitis patients who do not tolerate NB-UVB 
      but demonstrate an excellent clinical response to BB-UVB. It is critical for 
      dermatologists to recognize the role of BB-UVB as a complement to NB-UVB 
      phototherapy for patients who cannot tolerate or experience an inadequate 
      therapeutic response from NB-UVB.
FAU - Pugashetti, Rupa
AU  - Pugashetti R
AD  - University of California, Irvine School of Medicine, Irvine, CA, USA.
FAU - Lim, Henry W
AU  - Lim HW
FAU - Koo, John
AU  - Koo J
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - England
TA  - J Dermatolog Treat
JT  - The Journal of dermatological treatment
JID - 8918133
SB  - IM
MH  - Adult
MH  - Aged
MH  - Dermatitis, Atopic/*radiotherapy
MH  - Female
MH  - Humans
MH  - Middle Aged
MH  - Pruritus/*radiotherapy
MH  - Psoriasis/*radiotherapy
MH  - Severity of Illness Index
MH  - Treatment Outcome
MH  - Ultraviolet Therapy/adverse effects/*methods
EDAT- 2009/11/10 06:00
MHDA- 2011/02/02 06:00
CRDT- 2009/11/10 06:00
PHST- 2009/11/10 06:00 [entrez]
PHST- 2009/11/10 06:00 [pubmed]
PHST- 2011/02/02 06:00 [medline]
AID - 10.3109/09546630903341986 [pii]
AID - 10.3109/09546630903341986 [doi]
PST - ppublish
SO  - J Dermatolog Treat. 2010 Nov;21(6):326-30. doi: 10.3109/09546630903341986.